Skip to content
20-F

Annual Report (Foreign)

Altamira Therapeutics Ltd. CYTOF

0001213900-24-031734

← back to feed
Filed
Apr 10, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Structured financials aren't available for this filing — it may be an event-driven form (8-K/6-K), pre-date XBRL (~2009), or report only narrative content. Use the SEC.gov links above to read it.